Dana-Farber Research Looks at Blood Test to Detect Cancer

Dana-Farber’s Deborah Schrag, MD, MPH, is leading the Pathfinder Study, a study that looks at a simple blood test and evaluates it to see if it could detect multiple cancer types at the earliest and most treatable stages.


October 23, 2020

Created by


Related Presenters

Deborah Schrag, MD, MPH

Deborah Schrag, MD, MPH

Chief, Division of Population Sciences, Department of Medical Oncology

Dr. Schrag received her medical degree from Columbia University in New York in 1991. She subsequently completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at Dana-Farber Cancer Institute.

View Profile